Management of Severe Hypertension in the Postpartum Period with Intravenous Hydralazine or Labetalol: A Randomized Clinical Trial

200753 citationsJournal Article

Authors

Paulino Vigil‐De Gracia · Complejo Hospitalario Dr. Arnulfo Arias Madrid

Esteban Ruiz · Complejo Hospitalario Dr. Arnulfo Arias Madrid

Juan Carlos Rivero López · Complejo Hospitalario Dr. Arnulfo Arias Madrid

Ilka Alveo de Jaramillo · Complejo Hospitalario Dr. Arnulfo Arias Madrid

Juan C. Vega-Maleck · Complejo Hospitalario Dr. Arnulfo Arias Madrid

Jaime Pinzón · Complejo Hospitalario Dr. Arnulfo Arias Madrid

Abstract

This randomized clinical trial shows that intravenous hydralazine and intravenous labetalol are effective and safe in the management of severe hypertension in the postpartum period.

Topics & Keywords

Pregnancy and preeclampsia studies Maternal and fetal healthcare Cardiac, Anesthesia and Surgical Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hypertension in Pregnancy

Volume 26, Issue 2, pp. 163-171

DOI: 10.1080/10641950701204430

Field-Weighted Citation Impact: 2.91